Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults - Concepedia

Concepedia

Publication | Open Access

Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults

DOI Full Paper Access

413

Citations

13

References

2007

Year

Étienne Sokal, Karel Hoppenbrouwers, Corinne Vandermeulen, Michel Moutschen, Philippe Léonard, André Moreels, Michèle Haumont, Alex Bollen, Françoise Smets, Martine Denis

The Journal of Infectious Diseases

Abstract

ClinicalTrials.gov identifier: NCT00430534.

References

	Year	Citations

Page 1